A cognitive neuropsychological model of antidepressant drug action

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 7, 2011, Pages 1586-1592

  Pringle, A ^a   Browning, M ^a   Cowen, P J ^a   Harmer, C J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antidepressants; Emotional processing; Functional neuroimaging

Indexed keywords

AGOMELATINE; ANTIDEPRESSANT AGENT; APREPITANT; CITALOPRAM; CLOMIPRAMINE; DIAZEPAM; IMIPRAMINE; IPRONIAZID; MIRTAZAPINE; REBOXETINE; RIMONABANT;

AMYGDALOID NUCLEUS; ANGER; ANXIETY DISORDER; ARTICLE; COGNITION; DEPRESSION; DRUG EFFICACY; DRUG SCREENING; EMOTION; HUMAN; MOOD; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; PROCESS DEVELOPMENT; PROCESS MODEL; PSYCHOPHARMACOLOGY; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANTIDEPRESSIVE AGENTS; COGNITION; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; MODELS, PSYCHOLOGICAL; TIME FACTORS;

EID: 79961126531     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.07.022     Document Type: Article

References (71)

1. Airan R., Meltzer L., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
2. Allen N.B., Trinder J., Brennan C. Affective startle modulation in clinical depression: preliminary findings. Biol Psychiatry 1999, 46:542-550.
3. Arce E., Simmons A., Lovero K., Stein M., Paulus M. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology 2008, 196:661-672.
4. Arnone D., Horder J., Cowen P.J., Harmer C.J. Early effects of mirtazapine on emotional processing. Psychopharmacology 2009, 203:685-691.
5. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive therapy of depression 1979, Guildford Press, New York.
6. Bhagwagar Z., Cowen P., Goodwin G., Harmer C.J. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry 2004, 161:166-168.
7. Bouhuys A.L., Geerts E., Gordijn M.C. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: a longitudinal study. J Nerv Ment Dis 1999, 187:595-602.
8. Browning M., Reid C., Cowen P.J., Goodwin G.M., Harmer C.J. A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 2007, 21:684-690.
9. Browning M., Holmes E., Murphy S., Goodwin G., Harmer C.J. Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry 2010, 67:919-925.
10. de Almeida J.R., Phillips M.L., Cerqueira C.T., Zilberman M., Lobo D., Henna E., Tavares H., Amaro E., Gorenstein C., Gentil V., Busatto G.F. Neural activity changes to emotional stimuli in healthy individuals under chronic use of clomipramine. J Psychopharmacol 2010, 24:1165-1174.
11. Chan S., Goodwin G., Harmer C. Highly neurotic never-depressed students have negative biases in information processing. Psychol Med 2007, 37:1281-1291.
12. Chandra P., Hafizi S., Massey-Chase R.M., Goodwin G.M., Cowen P.J., Harmer C.J. NK1 receptor antagonism and emotional processing in healthy volunteers. J Psychopharmacol 2010, 24:481-487.
13. Chen A.C., Shirayama Y., Shin K., Neve R.L., Duman R.S. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 2001, 49:10.
14. Critchley H., Lewis P., Orth M., Josephs O., Deichmann R., Trimble M., Dolan R. Vagus nerve stimulation for treatment-resistant depression: behavioral and neural effects on encoding negative material. Psychosom Med 2007, 69:17-22.
15. Davis R., Wilde M.I. Mirtazapine: a review of its pharmacology and therapy potential in the management of major depression. CNS Drugs 1996, 5:4.
16. Dichter G., Tomarken A., Shelton R., Sutton S. Early- and late-onset startle modulation in unipolar depression. Psychophysiology 2004, 41:433-440.
17. Forbes E., Miller A., Cohn J., Fox N., Kovacs M. Affect-modulated startle in adults with childhood-onset depression: relations to bipolar course and number of lifetime depressive episodes. Psychiatry Res 2005, 134:11-25.
18. Fu C., Williams S., Cleare A., Brammer M., Walsh N., Kim J., Andrew C., Pich E.M., Williams P., Reed L., Mitterschiffthaler M., Suckling J., Bullmore E. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004, 61:877-889.
19. Fu C., Williams S., Brammer M., Suckling J., Kim J., Cleare A., Walsh N., Mitterschiffthaler M., Andrew C., Pich E.M., Bullmore E. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry 2007, 164:599-607.
20. Gilboa-Schechtman E., Erhard-Weiss D., Jeczemien P. Interpersonal deficits meet cognitive biases: memory for facial expressions in depressed and anxious men and women. Psychiatry Res 2002, 113:279-293.
21. Gotlib I., Krasnoperova E., Yue D.N., Joormann J. Attentional biases for negative interpersonal stimuli in clinical depression. J Abnorm Psychol 2004, 113:121-135.
22. Grillon C., Levenson J., Pine D. A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 2007, 32:225-231.
23. Gur R.C., Erwin R.J., Gur R.E., Zwil A.S., Heimberg C., Kraemer H.C. Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res 1992, 42:241-251.
24. Harmer C.J. Serotonin and emotional processing: does it help explain antidepressant drug action?. Neuropharmacology 2008, 55:1023-1028.
25. Harmer C.J. Antidepressant drug action: a neuropsychological perspective. Depress Anxiety 2010, 27:231-233.
26. Harmer C.J., Bhagwagar Z., Perrett D.I., Völlm B.A., Cowen P.J., Goodwin G.M. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003, 28:148-152.
27. Harmer C.J., Shelley N., Cowen P., Goodwin G. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 2004, 161:1256-1263.
28. Harmer C.J., Mackay C., Reid C., Cowen P., Goodwin G. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006, 59:816-820.
29. Harmer C.J., Heinzen J., O'Sullivan U., Ayres R.A., Cowen P.J. Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology 2008, 199:495-502.
30. Harmer C.J., Goodwin G., Cowen P. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 2009, 195:102-108.
31. Harmer C.J., O'Sullivan U., Favaron E., Massey-Chase R., Ayres R., Reinecke A., Goodwin G., Cowen P. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 2009, 166:1178-1184.
32. Harmer CJ, de Bodinat C, Dawson GR, Dourish CT, Waldenmeier L, Adams S, Cowen PJ, Goodwin G. Agomelatine facilitates positive versus negative affective processing in healthy volunteer models. J Psychopharmacol in press. doi:10.1177/0269881110376689.
33. Hayward G., Goodwin G., Cowen P., Harmer C.J, Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry 2005, 57:517-524.
34. Holick K.A., Lee D.C., Hen R., Duwala S. Behavioural effects of chronic fluoxetine in BALB/cj mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2008, 33:406-417.
35. Horder J., Cowen P., Di Simplicio M., Browning M., Harmer C.J. Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology 2009, 205:85-91.
36. Huang G.-J., Bannerman D., Flint J. Chronic Fluoxeteine treatment alters beavhiour, but not adult hippocampal neurogenesis in BALB/cj mice. Mol Psychiatry 2008, 13:119-121.
37. Joormann J., Talbot L., Gotlib I. Biased processing of emotional information in girls at risk for depression. J Abnorm Psychol 2007, 116:135-143.
38. Just N.A., Abramson L.Y., Alloy L.B. Remitted depression studies as a test of the cognitive vulnerability hypothesis of depression onset: a critique and conceptual analysis. Clin Psychol Rev 2001, 21:20.
39. Kempermann G. The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?. Trends Neurosci 2008, 31:163-169.
40. Kent J.M., Coplan J.D., Gorman J.M. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 1998, 44:812-824.
41. Krishnan V., Nestler E. The molecular neurobiology of depression. Nature 2008, 455:894-902.
42. Kuhn R. Treatment of depressive states with an iminodibenzyl derivative (G 22355). Schweiz Med Wochenschr 1957, 87:1135-1140.
43. Loomer H.P., Saunders J.C., Kline N.S. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep 1957, 8:129-141.
44. MacLeod C., Rutherford E., Campbell L., Ebsworthy G., Holker L. Selective attention and emotional vulnerability: assessing the causal basis of their association through the experimental manipulation of attentional bias. J Abnorm Psychol 2002, 111:107-123.
45. Malberg J., Blendy J. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 2005, 26:631-638.
46. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci Off J Soc Neurosci 2000, 20:9104-9110.
47. Malcolm C.P., Cowen P.J., Harmer C.J. High-density negative ion treatment increases positive affective memory. Psychol Med 2009, 39:1930-1932.
48. Mannie Z., Harmer C., Cowen P. Increased waking salivary cortisol levels in young people at familial risk of depression. Am J Psychiatry 2007, 164:617-621.
49. Mathews A., MacLeod C. Induced processing biases have causal effects on anxiety. Cognit Emotion 2002, 331-354.
50. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol 2005, 1:167-195.
51. Mathews A., Ridgeway V., Williamson D.A. Evidence for attention to threatening stimuli in depression. Behav Res Ther 1996, 34:695-705.
52. Mogg K., Bradley B.P., Williams R. Attentional bias in anxiety and depression: the role of awareness. Br J Clin Psychology 1995, 34(Pt 1):17-36.
53. Murphy S.E. Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs). Curr Pharm Design 2010, 16:1990-1997.
54. Murphy S.E., Downham C., Cowen P.J., Harmer C.J. Direct effects of diazepam on emotional processing in healthy volunteers. Psychopharmacology 2008, 199:503-513.
55. Murphy S., Yiend J., Lester K., Cowen P., Harmer C.J. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol 2009, 12:169-179.
56. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539-7547.
57. Norbury R., Mackay C., Cowen P., Goodwin G., Harmer C.J. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry 2007, 190:531-532.
58. Norbury R., Taylor M., Selvaraj S., Murphy S., Harmer C.J., Cowen P. Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology 2009, 206:197-204.
59. Pury C. Information-processing predictors of emotional response to stress. Cognit Emotion 2002, 16:667-683.
60. Ridout N., Astell A., Reid I., Glen T., O'Carroll R. Memory bias for emotional facial expressions in major depression. Cognit Emotion 2003, 17:101-122.
61. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Duwala S., Weisstaub N., Lee J., Duman K., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 2003, 301:805-809.
62. Satel S.L., Nelson J.C. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989, 50:241-249.
63. Schaefer H., Putnam K., Benca R., Davidson R. Event-related functional magnetic resonance imaging measures of neural activity to positive social stimuli in pre- and post-treatment depression. Biol Psychiatry 2006, 60:974-986.
64. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000, 48:9.
65. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001, 50:651-658.
66. Shirayama Y., Chen A.C.H., Nakagawa S., Russell D., Duman R. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22:3251-3261.
67. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997, 56:131-137.
68. Surguladze S., Brammer M., Keedwell P., Giampietro V., Young A., Travis M., Williams S., Phillips M. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 2005, 57:201-209.
69. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000, 20:4030-4036.
70. Tranter R., Bell D., Gutting P., Harmer C., Healy D., Anderson I. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord 2009, 118:87-93.
71. Windischberger C., Lanzenberger R., Holik A., Spindelegger C., Stein P., Moser U., Gerstl F., Fink M., Moser E., Kasper S. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage 2010, 49:1161-1170.